Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression

Interview with Ye Ella Tian, MBBS, PhD, and Andrew Zalesky, PhD, authors of Evaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders. Hosted by John Torous, MD. Related Content: Evaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders

Interview with Ziming Xuan, ScD, SM, and Alexander Y. Walley, MD, MSc, authors of Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities. Hosted by John Torous, MD, MBI. Related Content: Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities

Interview with Merete Nordentoft, DrMedSc, author of Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder: 20-Year Follow-up of the OPUS Trial. Hosted by John Torous, MD, MBI. Related Content: Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder

Interview with Cameron S. Carter, MD, author of Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis: A Cluster Randomized Clinical Trial. Hosted by John Torous, MD, MBI, and Kara Bagot, MD. Related Content: Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis

Interview with Jari Tiihonen, MD, PhD, author of Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. Hosted by John Torous, MD, MBI. Related Content: Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients

Interview with Weili Xu, PhD, author of Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia. Hosted by John Torous, MD, MBI. Related Content: Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia

Interview with Liane Schmidt, PhD, and Philippe Fossati, MD, PhD, authors of Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression. Hosted by John Torous, MD.

Interview with Angelica Ronald, PhD, author of Heritability of Heritability of Psychotic Experiences in Adolescents and Interaction With Environmental Risk . Hosted by John Torous, MD, MBI.

Interview with Michael P. Bogenschutz, MD, author of Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD. Related Content: Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

In July 2022, Kirsten Bibbins-Domingo, PhD, MD, MAS, took on a new role as the 17th editor in chief of JAMA and the JAMA Network. In conversation with Nobel laureate Harold Varmus, MD, Bibbins-Domingo discusses her research background, approaches to leadership in health care, and the critical role that journals play in communication about public health and science. Related Content: The Urgency of Now and the Responsibility to Do More—My Commitment for JAMA and the JAMA Network A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (video) A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief (audio)